Niyogi, SK, Mitra, U, Dutta, P. Changing patterns of serotypes and antimicrobial susceptibilities of Shigella species isolated from children in Calcutta, India. Japanese Journal of Infectious Disease
2001; 54: 121–122.
Vinh, H, et al.
A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation. BMC Infectious Disease
2009; 9: 204.
Jamsheer, AE, et al.
Trend of antibiotic resistance in 1316 Shigella strains isolated in Bahrain. Saudi Medical Journal
2003; 24: 424–426.
Chompook, P, et al.
Estimating the burden of shigellosis in Thailand: 36-month population-based surveillance study. Bulletin of the World Health Organization
2005; 83: 739–746.
Yang, HCG, et al.
Surveillance of antimicrobial susceptibility patterns among Shigella species isolated in China during the 7-year period of 2005–2011. Annals of Laboratory Medicine
2013; 33: 111–115.
Kosek, M, Bern, C, Guerrant, RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bulletin of the World Health Organization
2003; 81: 197–204.
Bryce, J, et al.
WHO estimates of the causes of death in children. Lancet
2005; 365: 1147–1152.
Kotloff, KL, et al.
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bulletin of the World Health Organization
1999; 77: 651–666.
WHO. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type. Geneva: World Health Organization.
Sur, D, et al.
Shigellosis: challenges and management issues. Indian Journal of Medical Research
2004; 120: 454–462.
Bhattacharya, SK, Sur, D. An evaluation of current shigellosis treatment. Expert Opinion in Pharmacotherapy
2003; 4: 1315–1320.
Watanabe, T. Infective heredity of multiple drug resistance in bacteria. Bacteriological Reviews
1963; 27: 87–115.
Sack, RB, et al.
Antimicrobial resistance in organisms causing diarrheal disease. Clinical Infectious Disease
1997; 24 (Suppl. 1): S102–S105.
Bhattacharya, K, et al.
Double-blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children. Acta Paediatrica
1997; 86: 319–320.
Green, S TG, Tilloston, G. Use of Ciprofloxacinrofloxacin in developing countries. Pediatric Infectious Disease Journal
1997; 16: 150–159.
Gu, B, et al.
Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009. International Journal of Antimicrobial Agents
2012; 40: 9–17.
Gu, B, et al.
Prevalence and trends monitoring of aminoglycoside resistance in Shigella worldwide, 1999–2010. Journal of Biomedical Research
2013; 27: 103–115.
Fortineau, N, et al.
SHV-type extended spectrum-lactamase in a Shigella flexneri clinical isolate. Journal of Antimicrobial Chemotherapy
2001; 47: 685–688.
Rahman, M, et al.
Extended-spectrum beta-lactamase-mediated third-generation cephalosporin resistance in Shigella isolates in Bangladesh. Journal of Antimicrobial Chemotherapy
2004; 54: 846–847.
Goel, N, et al.
Emergence of ceftriaxone resistant Shigella
. Indian Journal of Pediatrics
2013; 80: 70–71.
Vinh, H, et al.
Rapid emergence of third-generation cephalosporin resistant Shigella spp. in Southern Vietnam. Journal of Medical Microbiology
2009; 58: 281–283.
Taneja, N, et al.
Cephalosporin-resistant Shigella flexneri over 9 years (2001–09) in India. Journal of Antimicrobial Chemotherapy
2012; 67: 1347–1353.
Freeman, MF TJ. Transformations related to the angular and square root. Annals of the Institute of Statistical Mathematics
1950; 21: 607–611.
Tiruneh, M. Serodiversity and antimicrobial resistance pattern of Shigella isolates at Gondar University teaching hospital, Northwest Ethiopia. Japanese Journal of Infectious Disease
2009; 62: 93–97.
Opintan, J, Newman, MJ. Distribution of serogroups and serotypes of multiple drug resistant Shigella isolates. Ghana Medical Journal
2007; 41: 8–29.
Djie-Maletz, A RK, et al.
High rate of resistance to locally used antibiotics among enteric bacteria from children in Northern Ghana. Journal of Antimicrobial Chemotherapy
2008; 61: 1315–1318.
Bonkoungou, IJ, et al.
Bacterial and viral etiology of childhood diarrhea in Ouagadougou, Burkina Faso. BMC Pediatrics
2013; 13: 36.
Varsano, I, et al.
Comparative efficacy of ceftriaxone and ampicillin for treatment of severe shigellosis in children. Journal of Pediatrics
Seidlein, LV KD, Ali, M. A multicentre study of shigella diarrhea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Medicine
2006; 3: e353.
Srinivasa, H, Baijayanti, M, Raksha, Y. Magnitude of drug resistant Shigellosis: a report from Bangalore. Indian Journal of Medical Microbiology
2009; 27: 358–360.
Bradford, PA. Extended-spectrumb-lactamases in the 21st century: characterisation, epidemiology and detection of this important resistant threat. Clinical Microbiology Reviews
2001; 14: 933–951.
Lee, W, et al.
CTX-M-55-type extended-spectrum beta-lactamase-producing Shigella sonnei isolated from a Korean patient who had travelled to China. Annals of Laboratory Medicine
2013; 33: 141–144.
Marchou, B. Traveler's diarrheoa: epidemiology, clinical practice guideline for the prevention and treatment. Presse Medicale
2013; 42: 76–81.
Jeon, YL, et al.
Quinolone-resistant Shigella flexneri isolated in a patient who travelled to India. Annals of Laboratory Medicine
Takeshita, N. Travellers and multi-drug resistance bacteria. Nihon Rinsho
2012; 70: 324–328.
Mache, AMY, Cowly, S.
Shigella serogroups identified from adult diarrhoea out-patients in Addis Ababa, Ethiopia: antibiotic resistance and plasmid profile analysis. East African Medical Journal
1997; 74: 179–182.
Zhang, CL, et al.
Drug resistance and molecular epidemiology of Shigella isolated from children with diarrhea. Zhonghua Er Ke Za Zhi
2012; 50: 777–781.
Mariani-Kurkdjian, P, Doit, C, Bingen, E. Extended-spectrum beta-lactamase producing-enterobacteria. Arch Pediatrics
2012; 19 (Suppl. 3): S93–96.
Partridge, SR, et al.
Gene cassettes and cassette arrays in mobile resistance integrons. FEMS Microbiology Reviews
2009; 33: 757–784.
Perez-Moreno, MO, et al.
Beta-Lammases, transferable quinolone resistance determinants, and class 1 integron-mediated antimicrobial resistance in human clinical Salmonella enteric isolates of non-Typhimurium serotypes. International Journal of Medical Microbiology
2013; 303: 25–31.
Ke, X, et al.
Epidemiology and molecular mechanism of integron-mediated antibiotic resistance in Shigella
. Archives of Microbiology
2011; 193: 767–774.
Sack, DA HA, Huq, A, Etheridge, M. Is protection against shigellosis induced by natural infection with Pleonasms shigellosis?
1994; 343: 1413–1415.
Genobile, D, et al.
An outbreak of shigellosis in a child care center. Communicable Disease Intelligence Quarterly Report
2004; 28: 225–229.
Lewis, HC, et al.
Outbreaks of Shigella sonnei infections in Denmark and Australia linked to consumption of imported raw baby corn. Epidemiology and Infection
2009; 137: 326–334.
Cohen, D, et al.
Reduction of transmission of shigellosis by control of houseflies (Musca domestica). Lancet
1991; 337: 993–997.
Holt, KE, et al.
Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe. Nature Genetics
2012; 44: 1056–1059.
Yang, H, et al.
Serotype distribution and characteristics of antimicrobial resistance in Shigella isolated from Henan province, China, 2001–2008. Epidemiology and Infection
2013; 141: 1946–1952.
Kaminski, RW, Oaks, EV. Inactivated and subunit vaccines to prevent shigellosis. Expert Review of Vaccines
2009; 8: 1693–1704.
Martinez-Becerra, FJ, et al.
Broadly protective Shigella vaccine based on type III secretion apparatus proteins. Infection and Immunity
2012; 80: 1222–1231.
Steele, D, et al.
Vaccines for enteric diseases: a meeting summary. Expert Review of Vaccines
2012; 11: 407–409.
Levine, MM, et al.
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nature Reviews Microbiology
2007; 5: 540–553.
Osorio, M, Bray, MD, Walker, RI. Vaccine potential for inactivated shigellae
2007; 25: 1581–1592.
Nga do, TT, et al.
Antibiotic sales in rural and urban pharmacies in northern Vietnam: an observational study. BMC Pharmacology and Toxicology
2014; 15: 6.
Wirtz, VJ, et al.
Analysing policy interventions to prohibit over-the-counter antibiotic sales in four Latin American countries. Tropical Medicine and International Health
2013; 18: 665–673.
Du, HC, John, DN, Walker, R. An investigation of prescription and over-the-counter supply of opthalmic chloramphenicol in Wales in the 5 years following reclassification. International Journal of Pharmacy Practice
2014; 22: 20–27.